Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I. Kawano N, et al. Among authors: ochiai h. J Clin Exp Hematop. 2018 Sep 19;58(3):107-121. doi: 10.3960/jslrt.18011. Epub 2018 Aug 8. J Clin Exp Hematop. 2018. PMID: 30089749 Free PMC article. Clinical Trial.
Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture.
Kawano N, Ochiai H, Yoshida S, Yamashita K, Shide K, Shimoda H, Hidaka T, Kubuki Y, Katayose K, Toyama T, Kawano H, Matsuoka H, Ishizaki J, Maeda K, Satou S, Yano T, Yamaguchi K, Takenaka K, Shimao Y, Oshima K, Ueda A, Shimoda K. Kawano N, et al. Among authors: ochiai h. Int J Clin Oncol. 2012 Aug;17(4):336-40. doi: 10.1007/s10147-011-0292-5. Epub 2011 Sep 10. Int J Clin Oncol. 2012. PMID: 21904968
Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Yoshida S, Ono N, Himeji D, Nagahiro Y, Sayaka Kawano, Yamashita K, Ikeda N, Uezono S, Ochiai H, Kawano F, Kikuchi I, Ishikawa F, Shimoda K, Ueda A, Akashi K. Kawano N, et al. Among authors: ochiai h. J Clin Exp Hematop. 2011;51(2):101-7. doi: 10.3960/jslrt.51.101. J Clin Exp Hematop. 2011. PMID: 22104308 Free article.
Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A. Kawano N, et al. Among authors: ochiai h. Intern Med. 2013;52(1):55-62. doi: 10.2169/internalmedicine.52.7978. Epub 2013 Jan 1. Intern Med. 2013. PMID: 23291674 Free article.
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N, Tasaki A, Kuriyama T, Tahara Y, Yoshida S, Ono N, Himeji D, Yamashita K, Shibata Y, Goto T, Inoue T, Yokota-Ikeda N, Uezono S, Yuge A, Nishiguchi T, Kinjo T, Ogura Y, Beppu K, Ueda Y, Kinoshita M, Moritake H, Shimoda K, Ochiai H, Ueda A. Kawano N, et al. Among authors: ochiai h. Intern Med. 2014;53(3):205-13. doi: 10.2169/internalmedicine.53.0715. Intern Med. 2014. PMID: 24492688 Free article.
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Kawano N, Yoshida S, Kuriyama T, Tahara Y, Yamashita K, Nagahiro Y, Kawano J, Koketsu H, Toyofuku A, Manabe T, Beppu K, Ono N, Himeji D, Yokota-Ikeda N, Inoue S, Ochiai H, Sonoda KH, Shimoda K, Ishikawa F, Ueda A. Kawano N, et al. Among authors: ochiai h. Intern Med. 2015;54(12):1489-98. doi: 10.2169/internalmedicine.54.1953. Epub 2015 Jun 15. Intern Med. 2015. PMID: 26073237 Free article.
Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
Kawano N, Kuriyama T, Sonoda KH, Yoshida S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Ueda A, Kikuchi I. Kawano N, et al. Among authors: ochiai h. Intern Med. 2016;55(11):1439-45. doi: 10.2169/internalmedicine.55.6312. Epub 2016 Jun 1. Intern Med. 2016. PMID: 27250049 Free article.
The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Kawano N, Kuriyama T, Yoshida S, Kawano S, Yamano Y, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I. Kawano N, et al. Among authors: ochiai h. J Clin Exp Hematop. 2017;56(3):135-144. doi: 10.3960/jslrt.56.135. J Clin Exp Hematop. 2017. PMID: 28331127 Free PMC article.
Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.
Kawano N, Nagahiro Y, Yoshida S, Tahara Y, Himeji D, Kuriyama T, Tochigi T, Nakaike T, Shimokawa T, Yamashita K, Ochiai H, Marutsuka K, Mashiba K, Shimoda K, Teshima T, Kikuchi I. Kawano N, et al. Among authors: ochiai h. J Clin Exp Hematop. 2019;59(4):156-167. doi: 10.3960/jslrt.18032. J Clin Exp Hematop. 2019. PMID: 31866618 Free PMC article. Clinical Trial.
780 results